1
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: the impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
2
|
Kaneda H, Arao T, Tanaka K, et al: FOXQ1
is overexpressed in colorectal cancer and enhances tumorigenicity
and tumor growth. Cancer Res. 70:2053–2063. 2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Sasisekharan R, Shriver Z, Venkataraman G
and Narayanasami U: Roles of heparan-sulphate glycosaminoglycans in
cancer. Nat Rev Cancer. 2:521–528. 2002. View Article : Google Scholar : PubMed/NCBI
|
4
|
Sanderson RD: Heparan sulfate
proteoglycans in invasion and metastasis. Semin Cell Dev Biol.
12:89–98. 2001. View Article : Google Scholar : PubMed/NCBI
|
5
|
Matsuda K, Maruyama H, Guo F, Kleeff J,
Itakura J, Matsumoto Y, Lander AD, et al: Glypican-1 is
overexpressed in human breast cancer and modulates the mitogenic
effects of multiple heparin-binding growth factors in breast cancer
cells. Cancer Res. 61:5562–5569. 2001.PubMed/NCBI
|
6
|
Conejo JR, Kleeff J, Koliopanos A, Matsuda
K, Zhu ZW, Goecke H, et al: Syndecan-1 expression is up-regulated
in pancreatic but not in other gastrointestinal cancers. Int J
Cancer. 88:12–20. 2000. View Article : Google Scholar : PubMed/NCBI
|
7
|
Ashikari-Hada S, Habuchi H, Kariya Y, Itoh
N, Reddi AH and Kimata K: Characterization of growth factor-binding
structures in heparin/heparan sulfate using an octasaccharide
library. J Biol Chem. 279:12346–12354. 2004. View Article : Google Scholar : PubMed/NCBI
|
8
|
Pye DA, Vives RR, Turnbull JE, Hyde P and
Gallagher JT: HS oligosaccharides require 6-O-sulphation for
promotion of basic fibroblast growth factor mitogenic activity. J
Biol Chem. 273:22936–22942. 1998.PubMed/NCBI
|
9
|
Robinson CJ, Harmer NJ, Goodger SJ,
Blundell TL and Gallagher JT: Cooperative dimerization of
fibroblast growth factor 1 (FGF1) upon a single heparin saccharide
may drive the formation of 2:2:1 FGF1.FGFR2c.heparin ternary
complexes. J Biol Chem. 280:42274–42282. 2005. View Article : Google Scholar : PubMed/NCBI
|
10
|
Ai X, Do AT, Kusche-Gullberg M, Lindahl U,
Lu K and Emerson CP Jr: Substrate specificity and domain functions
of extracellular heparin sulfate 6-O-endosulfatases, QSulf1
and QSulf2. J Biol Chem. 281:4969–4976. 2006. View Article : Google Scholar : PubMed/NCBI
|
11
|
Labbé E, Lock L, Letamendia A, et al:
Transcriptional cooperation between the transforming growth
factor-beta and Wnt pathways in mammary and intestinal
tumorigenesis. Cancer Res. 67:75–84. 2007.PubMed/NCBI
|
12
|
Backen AC, Cole CL, Lau SC, et al: Heparan
sulphate synthetic and editing enzymes in ovarian cancer. Br J
Cancer. 96:1544–1548. 2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Song K, Li Q, Peng YB, Li J, Ding K, et
al: Silencing of hHS6ST2 inhibits progression of pancreatic cancer
through inhibition of Notch signalling. Biochem J. 436:271–282.
2011. View Article : Google Scholar : PubMed/NCBI
|
14
|
Pollari S, Käkönen RS, Mohammad KS, et al:
Heparin-like polysaccharides reduce osteolytic bone destruction and
tumor growth in a mouse model of breast cancer bone metastasis. Mol
Cancer Res. 10:597–604. 2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Esko JD and Selleck SB: Order out of
chaos: assembly of ligand binding sites in heparan sulfate. Annu
Rev Biochem. 71:435–471. 2002. View Article : Google Scholar : PubMed/NCBI
|
16
|
Persimmon N and Bernfield M: Specificities
of heparan sulfate proteoglycans in developmental processes.
Nature. 404:725–728. 2000. View
Article : Google Scholar
|
17
|
Nakato H and Kimata K: Heparan sulfate
fine structure and specificity of proteoglycan functions. Biochem
Biopsy Acta. 1573:312–318. 2002. View Article : Google Scholar : PubMed/NCBI
|
18
|
Chen E, Stringer SE, Rusch MA, Selleck SB
and Ekker SC: A unique role for 6-O sulfation modification
in zebrafish vascular development. Dev Biol. 284:364–376. 2005.
|
19
|
Lundin L, Larsson H, Kreuger J, Kanda S,
Lindahl U, Salmivirta M and Claesson-Welsh L: Selectively
desulfated heparin inhibits fibroblast growth factor-induced
mitogenicity and angiogenesis. J Biol Chem. 275:24653–24660. 2000.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Nagai N, Habuchi H, Esko JD and Kimata K:
Stem domains of heparan sulfate 6-O-sulfotransferase are
required for Golgi localization, oligomer formation and enzyme
activity. J Cell Sci. 117:3331–3341. 2004.PubMed/NCBI
|